A carregar...

Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration

Fusidic acid (FA), which was approved in the 1960s in many European and Asian countries, has gained renewed interest due to its continued effectiveness against methicillin-resistant Staphylococcus aureus. As rhabdomyolysis has been reported upon coadministration of FA with statins, we aimed to eluci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Gupta, Anshul, Harris, Jennifer J., Lin, Jianrong, Bulgarelli, James P., Birmingham, Bruce K., Grimm, Scott W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5038258/
https://ncbi.nlm.nih.gov/pubmed/27458210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01335-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!